Skip to main content

Articles

Payers' Guide, FDA Approvals
Kyprolis: A New Treatment Option for Patients with Relapsed/Refractory Multiple Myeloma Previously Treated with Bortezomib and an Immunomodulatory Agent
Read More
Payers' Guide, FDA Approvals
Jentadueto: A New Oral Antihyperglycemic Combination Therapy for Patients with Type 2 Diabetes
Read More
Payers' Guide, FDA Approvals
Abraxane Receives New Indication for Locally Advanced or Metastatic Non–Small-Cell Lung Cancer When Curative Surgery or Radiation Therapy Is Not an Option
Read More
FDA Approvals, Payers' Guide
FDA Approvals of Brand-Name Prescription Drugs in 2012
Read More
FDA Approvals, Payers' Guide
Foreword: The Fourth Annual Payers’ Guide to New FDA Approvals
Read More
FDA Approvals, Payers' Guide
Introduction: New FDA Drug Approvals in 2012: A 15-Year High
Read More
Practice Management
A Value-Based Analysis of Hemodynamic Support Strategies for High-Risk Heart Failure Patients Undergoing a Percutaneous Coronary Intervention
Stakeholder Perspective
Careful Selection of Candidates for Percutaneous Ventricular Assist Device Is Crucial
Read More
Practice Management, Technology
Investing in Information Technology Pays Off: Meaningful Use Stage 1 Met by Majority of US Hospitals
Read More
Practice Management
The Value of Actionable Content in a Clinical Setting: Access to Better Information Facilitates Enhanced Cancer Care
Read More
Original Research
Effectiveness and Costs of TNF-Alpha Blocker Use for Patients with Rheumatoid Arthritis
Stakeholder Perspective
Assessing the Value of TNF-Alpha Blockers for Patients with Rheumatoid Arthritis
Read More
Page 180 of 244
Results 1791 - 1800 of 2434